The 2-Year Medicare Wait That Can Cost Lives

Why It Matters

The two‑year Medicare gap significantly elevates death risk for disabled workers, prompting urgent reconsideration of policy exemptions to prevent avoidable fatalities while weighing fiscal consequences.

Key Takeaways

• Two-year Medicare waiting period raises SSDI mortality fivefold.
• 2011‑2019 mortality rose due to shifting beneficiary composition.
• Cancer‑related SSDI beneficiaries face 39% two‑year death rate.
• Removing waiting period could add $110 billion to deficit.
• Targeted condition carve‑outs may reduce deaths during waiting period.

Summary

The podcast examines the two‑year Medicare enrollment lag imposed on Social Security Disability Insurance (SSDI) recipients and its stark health consequences. Dr. David Powell explains that the waiting period, created in 1972 to curb costs, leaves newly disabled workers without reliable coverage for 24 months, a gap that recent research shows translates into dramatically higher mortality.

Analyzing SSDI cohorts from 2000 to 2019, Powell’s team finds a two‑year mortality rate of roughly 6%, five to six times the age‑adjusted national average of just over 1%. The risk is especially acute for certain diagnoses: cancer‑related impairments see a 39.3% death rate, while digestive and blood disorders exceed 11% and 8% respectively. After 2011, overall mortality rose, driven not by worsening health per se but by a changing composition of beneficiaries entering the program.

Powell cites historical motives—concern over Medicare’s budget and the desire to avoid subsidizing already‑insured workers—as the basis for the lag. A 2008 Congressional Budget Office estimate warned that eliminating the waiting period could swell the federal deficit by $110 billion (in 2008 dollars). Earlier pilot programs, such as the accelerated benefits experiment, demonstrated that providing immediate coverage improves utilization and self‑reported health, though it lacked power to detect mortality effects.

The findings revive policy debates about whether to maintain, shorten, or selectively waive the waiting period. Targeted carve‑outs for high‑mortality conditions, akin to the 1972 ESRD exemption and the 2000 ALS exemption, could save lives without incurring the full fiscal impact of universal coverage. Updated cost‑benefit analyses are needed to balance budgetary constraints against the human toll of delayed Medicare access.

Original Description

Health Affairs' Rob Lott interviews David Powell of the University of Pennsylvania about his recent paper exploring new research showing SSDI beneficiaries face significantly elevated mortality during the mandatory two‑year waiting period for Medicare for such beneficiaries, why the waiting period exists, how it affects access to care, and what policy options could better serve this vulnerable population.

---

Visit Health Affairs: http://www.healthaffairs.org

Subscribe and Listen to our Podcasts: https://www.healthaffairs.org/podcasts

Sign up for our free Newsletters: https://www.healthaffairs.org/newsletters